Improved treatments for infections caused by often-deadly antibiotic-resistant bacteria may result from a recent discovery by University of Guelph microbiologists.
By studying how methicillin-resistant Staphylococcus aureus (MRSA) colonizes and infects human hosts, the researchers have found a potential drug target to strengthen existing treatments to overcome antimicrobial resistance (AMR).
Their paper appears online this week in the Proceedings of the National Academy of Sciences [1]. READ MORE [2]